We show that IL-36α induced maturation of human MDDCs and stimulated differentiation of IFN-γ producing (Type 1) CD3+ lymphocytes but was not as effective as IL-36β in doing so. For the first time, we also show that IL-36α induced expression of CD14 by MDDCs and this was highly potentiated by co-cultured with
Introduction
In the past decade, new members of the IL-1 family of cytokines have been described but there is still very little data reported on their biological effects and virtually nothing is known about these cytokines in the context of the human immune system.
Recently it has been shown that human monocyte derived dendritic cells (MDDCs) mature when stimulated with novel IL-1 cytokines (IL-36β or IL-36γ) and that IL-36β-matured MDDCs induce differentiation of T helper (type 1) (Th1) lymphocytes [1] . However, it is not known whether IL-36α, which also signals via the same receptor (IL-36R), has the same effect on maturation. Furthermore, nothing has been reported regarding the effect of novel IL-1 cytokines in conjunction with other DC maturation signals such as IFN-γ. IFN-γ is known to increase the expression of maturation markers, such as CD80, CD86, CD83 and HLA-DR, on the surface of MDDCs [2, 3] , while other studies have shown that MDDC maturation is also associated with increased expression of HLA-DR [4] and CD83 [5] and decreased expression of CD1a [6] . IFN-γ is also known to potentiate the maturation of MDDCs by IL-1β [2] but it is not known whether IFN-γ potentiates maturation of MDDCs by novel IL-1 cytokines.
Another important function of IFN-γ is in clearing pathogenic bacteria, such as salmonella, and in this case the highest concentration of IFN-γ is produced by Th1 lymphocytes which enter intestinal tissue from the blood [7] . IFN-γ produced by these cells activates innate immune cells by increasing phagocytosis and upregulating cellular killing pathways [8] [9] [10] [11] . Therefore, the induction of Th1 cells by novel IL-1 cytokines may have an effect on bacterial immunity, while it has also been reported that culture of TLR4 expressing MDDCs with IFN-γ also induces production of and IL-27 which makes lymphocytes more receptive to IL-12 [3] . Thus, IFN-γ may have a bi-directional effect on the activation of DCs and Th1 lymphocytes and it is possible that this may be affected by novel IL-1 cytokines, which induce Th1 proliferation, via DC maturation.
There is some evidence to suggest that MDDCs do represent a physiological population which replenish resident tissue DCs following infection [12] [13] . However, differentiation of monocytes to MDDCs is associated with loss of CD14 expression and an increase in CD11c is increased. These are contradictory effects since both are important in the recognition of Gram negative bacteria. The important role of CD14 in LPS recognition by innate immune cells has been known for a number of years [reviewed 14] , while CD11c increases phagocytosis of iC3b-opsonized particles [15] and has been shown to induce LPS responsiveness [16] . However, nothing has been reported on the effect of IFN-γ on CD14 and CD11c expression by MDDCs matured with novel IL-1 cytokines and it is possible that these MDDCs remain responsive to Gram negative bacteria (by maintaining CD14 expression) when stimulated with IFN-γ, or other cytokines which are produced during infection.
The aims of the study we report were; (1) to determine whether IL-36α increased maturation of MDDCS. (2) To determine whether IFN-γ synergised with IL-36α to induce maturation of MDDCs (as is the case with IL-1β). (3) Determine how these events may influence expression of CD14 and CD11c, which are important in detecting gram negative bacteria.
Materials and Methods

Reagents
Unless otherwise stated all laboratory reagents were purchased from Sigma, Poole, UK and all antibodies were purchased from Serotec, Oxford, UK. Recombinant human IL-36α and IL-36β proteins, and murine anti-human IL-36R were supplied by the Amgen, Corporation, Seattle, Washington, USA.
Bioethics
All studies were conducted following approval by local ethics committees.
Endotoxin assays
A kinetic chromogenic LAL assay (Lonza, USA) was performed by a verified technician prior to shipment of IL-1 reagents by Amgen. Assay sensitivity is between 0.005-50.0 EU/ml. Results showed LPS concentrations of < 0.209, which are equivalent to << 0.01 pg/ml in 100 ng IL-1 protein, were used in cell culture. Similar results were obtained at Nottingham prior to use. As an additional test for LPS contamination we used a THP 1 sensitivity assay which showed that the cells did not produce TNFα in response to IL-1 reagents but did produce TNFα when stimulated with bacterial lipopolysaccharide (data not shown). (see table 1 ). Cells were then analysed using a FACSCanto II analyser (Becton Dickinson, USA). Samples were acquired using CellQuest pro software (Becton Dickinson, USA) and analysed using WinMDI 2.8 software. Cell viability was assessed by propidium iodide uptake (20 μg/ml for 10 min) via FACS analysis and was found to be > 90% in all cases.
FACS analyses
Differentiation and culture of monocyte derived dendritic cells (MDDCs)
Blood products from healthy donors were obtained from the National blood transfusion service (Sheffield, UK). Isolation of peripheral blood monocytes (PBMs)
was performed using differential centrifugation in histopaque 1077 by standard methods. Briefly, 10 6 cells/ml were cultured in 6 well plates containing supplemented RPMI media (see above) with additional GM-CSF (50 ng/ml) and IL-4 (10 ng/ml) for 5 days.
Analysis of MDDC phenotype and maturation status.
Expression of CD1a, CD11c, CD14 and HLA-DR were measured by FACS analyses (as previously stated). The phenotype of these cultured cells was To assess IL-36α-dependant maturation of MDDCs, changes in HLA-DR, CD1.a, CD40, CD80, CD83 and CD86 expression were assessed by FACS analysis on the surface of day 5 (Immature) MDDCs which had been washed 3 times in PBS prior to incubation with IL-36α (500 ng/ml) for 48h. Expression of these maturation markers was then compared with expression of these markers on the surface of unstimulated day 5 MDDCs which were washed and cultured in media only for a further 48 or, as an additional control, MDDCs incubated with relevant isotype controls.
In a separate series of experiments, maturation of MDDCs, following culture with IL-36α or IL-36β (500 ng/ml), was compared with maturation following culture with IFN-γ (100 ng/ml) or following co-culture with IL-1 cytokine and IFN-γ. In other experiments, MDDCs were cultured with S. Typhimurium LPS (100 ng/ml).
T lymphocyte proliferation assays
Following maturation of MDDCs with IL-36α, the MDDCs were co-cultured with allogeneic CD3+ lymphocytes at a ratio of 1:50 for 96h.
T cell proliferation was measured after 96h using CellTiter 96 AQueous One Solution
Cell Proliferation Assay (Promega, Madison, USA) according to manufacturers instructions. Values were compared to those obtained from a standard curve with a maximum value of 1 x 10 6 CD3+ lymphocytes. As a positive control CD3+
lymphocytes were cultured for 96h in media containing Concanavalin A (10 g/ml).
Further comparison was made between IL-36α-matured MDDCs and MDDCs matured with IL-36β (500 ng/ml) and IL-1β (100 ng/ml)) prior to proliferation analysis and as a negative control CD3+ lymphocytes were cultured for 96h in media containing no additional supplements. All samples were cultured in triplicate and repeated on 3 separate occasions.
Determination of the cytokine profile of IL-36α-matured MDDCs and T lymphocytes stimulated with IL-36α -matured MDDCs
Immature MDDCs were stimulated with IL-36α (500 ng/ml) or IL-1F2 (10 ng/ml or 100 ng/ml) for 48h. After 48h, a standard ELISA analysis was used to measure IL-12 p70 and IL-18 in the MDDC supernatants. As a negative control, cell supernatants were obtained from immature (day 5) MDDCs which had been washed and cultured for 48h in media containing no supplements. As a positive control (and to provide comparative data) the affect of IL-36β (500 ng/ml) or IL-1 β (100 ng/ml) on IL-12
and IL-18 production was also measured. To determine T cell phenotypes differentiated by IL-1-matured MDDCs, analysis of IL-10 and IFN-γ concentrations were performed using standard ELISA analyses in supernatants obtained after 96h coculture of MDDCs with CD3+ lymphocytes (as stated above).
Measurement of the phagocytic capacity of MDDC cultured with or without cytokine.
S. Typhimurium strain 4/74 was cultured to mid-log phase prior to counting colony forming units (CFU) and assessment of growth. When required for use, Salmonella were diluted to give a multiplicity of infection (MOI) of 10 prior to co-culturing with day 6 MDDC, day 5 MDDC cultured with IL-36α (500 ng/ml) for 48h prior to the addition of Salmonella or day 5 MDDC cultured with IL-36α (500 ng/ml) and IFN-γ (100 ng/ml) for 24h prior to the addition of Salmonella. After 2h culture, the MDDCs were washed 3 times by centrifugation in PBS and then lysed using Triton x-100 (0.5% v/v) (Sigma). Salmonella CFU were then counted in lysed cells. Each experiment was performed in quadruplicate on 3 separate occasions.
Measurement of iC3b binding to IL-36α stimulated MDDCs
Day 5 MDDCs, which had been incubated with IL-36α (500 ng/ml), IFN-γ (100 ng/ml) or co-cultured with IL-36α and IFN-γ, for 48h were washed 3 times in PBS. 
RNA extraction
RNA extraction (using RNeasy mini kits) and DNase digestions were performed using standard procedures recommended by the kit manufacturer (Qiagen, Crawley, UK). The concentration of RNA was determined using a Nanodrop (ND1000) spectrophotometer (NanoDrop technologies, Wilmington, DE, USA) according to the manufacturer's instructions. A260/A280 ratio greater than 1.8 was considered to be pure. Reverse transcription was performed using a Transcriptor First Strand cDNA Synthesis Kit (Roche, West Sussex, UK) according to manufacturers instructions. 
Measurement of IL-36R
Statistical Analysis
An analysis of variance (ANOVA) test with a one-way classification was used to calculate significant differences (P < 0. 
Results
IL-36α induces maturation of human MDDCs
We investigated whether, or not, IL-36α induced MDDC maturation, as previously shown with IL-36β and IL-36γ. In comparison with isotype controls (Fig 1A) , expression of both HLA-DR and CD1a was increased on the surface of immature MDDCs (monocytes cultured for 5 days with GM CSF/IL-4) and cultured for 48h in culture media without cytokines (Fig 1B) . A distinct population of CD1a high /HLA-DR med MDDCs (which represented > 70% of the total population in all replicates) was gated as (R1) for comparison with the same population following cytokine treatment.
When immature MDDCs were cultured with IL-36α for 48h CD1a expression decreased and HLA-DR expression was increased, with the R1 population representing < 40 % of the total MDDC population in all replicate experiments ( Fig   1C) . As an additional marker of MDDC maturation, CD83 was measured on the surface of all control and test samples. Our data shows that CD83 expression was increased on the surface of MDDCs cultured with IL-36α for 48h compared to MDDCs which had been cultured without cytokine for the same time period (Fig 1D) .
IL-36 α induces expression of CD40 but not CD80 or CD86 on the surface of
MDDCs.
We investigated the expression of essential co-stimulatory molecules, required for full activation of cognate lymphocytes, by MDDCs cultured with IL-36α. Following incubation of immature MDDCs with IL-36α (500 ng/ml) for 48h. Our data showed that IL-36α increased expression of CD40, compared to either unstimulated MDDCs or isotype controls (Fig 2A) . However, IL-36α had no effect on either CD80/CD86 expression (Fig 2A) or CD86, which remained at levels expressed by unstimulated
MDDCs.
IL-36α stimulates production of pro-inflammatory cytokines (IL-12p70 and IL-
from human MDDCs
We next investigated whether production of IL-12p70 and/or IL-18 from immature concentrations measured in the supernatants isolated from unstimulated MDDCs ( Fig   3A) . However, IL-12p70 concentrations induced by IL-36α were lower than those induced by either IL-36 β or IL-1β but this difference was not significant (P > 0.05) (Fig 3A) . IL-36α (and IL-36 β or IL-1β) also stimulated a significant increase in IL-18 production when cultured with immature MDDCs for 48h (Fig 3B) . The concentration of IL-18 induced by IL-36 β was, again, lower than IL-18 production stimulated by either IL-36 β or IL-1β and in the latter case the difference was significant (P < 0.05) (Fig 3B) .
IL-36α -matured MDDCs induce proliferation of Th1 lymphocytes in allogeneic
MDDC/CD3+ lymphocyte cultures
MDDCs, which had been matured by culture with IL-36α for 48h, were cultured for 5 days with allogeneic CD3+ lymphocytes to determine whether they increased lymphocyte proliferation and skewed the phenotypic characteristic towards Th1 (proinflammatory), as is the case with IL-1β and IL-36β, or Th2 (anti-inflammatory). Our results showed that IL-36α induced a > 2 fold increase in CD3+ numbers compared to the number of CD3+ lymphocytes cultured for 5 days without MDDCs (Fig 6A) .
When the effect of IL-36α-matured MDDCs on lymphocyte proliferation was compared to positive controls, IL-36α maturation induced a comparative response to con A (> 2 fold increase) but a lesser effect when compared to either IL-36β or IL-1β (> 3 fold) (Fig 4A) . IL-36α -matured MDDCs also stimulated a significant increase (P < 0.05) in IFN-γ concentration in the supernatants isolated from allogeneic MDDC/CD3+ lymphocyte cultures but this was also significantly lower (P < 0.05) than IFN-γ concentrations induced by either IL-36β or IL-1β-matured MDDCs ( Fig   4B) . IL-10 concentration in supernatants isolated from allogenic cultures was slightly raised (~ pg/ml) when MDDCs were matured by IL-36α, IL-36β or IL-1β but this was not significant (P < 0.05) (Fig 4C) .
IL-36α and IL-36β induces CD14 expression by human MDDCs and synergise
with IFN-γ to produce a CD14 high /CD11c high MDDCs phenotype FACS analyses were used to measure expression of CD14 and CD11c on the surface of immature MDDCs cultured with IL-1 cytokines and/or IFN-γ for 48h and these were compared to relevant isotype controls (Fig 5A) . Although this study was primarily about IL-36α, nothing has been published regarding the affect of IL-36β on these important innate immune molecules. Our data showed that monocytes expressed a characteristic CD14 high /CD11c low phenotype (Fig 5B) and when these were differentiated into MDDC following 5 days of culture with GM CSF and IL-4 the phenotype shifted to the characteristic phenotype of MDDCs, CD14 low /CD11c high ( Fig 5C) . We then stimulated MDDCs with LPS for 48h and this had no effect on relative CD14 or CD11c expression (Fig 5D) . However, when MDDC were cultured with either IFN-γ ( Fig 5D) ; IL-36α (Fig 5E) or IL-36β ( Fig 5F) the phenotype shifted towards increased CD14 expression and decreased expression of CD11c. Our next series of experiments investigated whether IL-36α or IL-36β synergised with IFN-γ to affect expression of CD14 and CD11c. We show that there was a clear increase in CD14 expression and a return to high CD11c when MDDCs were co-cultured for 48h with IL-36α and IFN-γ (Fig 5G) or IL-36β and IFN-γ ( Fig   5I) .
IL-36α and IFN-γ synergistically increases binding of iC3b on the surface of
MDDCs but not phagocytosis of Gram negative bacteria (Salmonella
Typhimurium)
Since CD 11c binds iC3b to the surface of cells, and CD11c expression was synergistically increased on the surface of MDDCs cultured with both IL-36α and IFN-γ, we investigated whether, or not, this also lead to synergistic increases in binding of iC3b on the surfaced of MDDCs. The synergistic effect of IL-36α and IFN-γ was measured by increased interaction of iC3b (an opsonin which binds to CD11c) on the surface of MDDCs when compared to either cytokines alone, although both cytokines increased iC3b interaction in comparison to unstimulated MDDCs (Fig 6A) .
However, our data shows that although IL-36α stimulated MDDCs phagocytosed more bacteria than unstimulated (age matched) MDDCs the increase was not significant (P >0.05) but was significant (P <0.05) if MDDCs were cultured with both IL-36α and IFN-γ (Fig 8B) . When MDDCs were stimulated with IFN-γ only, the number of bacteria phagocytosed increased still further (compared with co-culture of
MDDCs with IL-36α and IFN-γ) but this increase was not significant (Fig 6B) IL-36α and IFN-γ stimulate similar levels of CD1a and CD83 expression by
MDDCs but IL-36α is less potent in inducing HLA-DR
To test whether any synergistic effects attributed to stimulation of MDDCs with both IL-36α and IFN-γ were simply due to increased MDDC maturation, we measured expression of CD1a, CD83 and HLA-DR on the surface of immature MDDCs which had been subsequently cultured with IL-36α or IFN-γ or co-cultured with IL-36α and IFN-γ for 48h. When MDDCs were cultured with IL-36α or IFN-γ or co-cultured with IL-36α and IFN-γ for 48h, expression of CD1a (Fig 7A) and CD83 (Fig 7B) was comparable and all were above isotype control levels. However, when HLA-DR expression by MDDCs was measured following these treatments, IL-36α induced less expression than was measured for IFN-γ, which itself induced a similar level of HLA-DR expression measured when MDDCs were co-cultured with IL-36α and IFN-γ ( Fig   7C) .
Discussion
Our results show that IL-36α induces maturation of human MDDCs, as measured by increased expression of CD83 and HLA-DR and decreased expression of CD1a. IL-36α also stimulated IL-12p70 and IL-18 production from MDDCs and the differentiation of (IFN-γ-producing) Th1 lymphocytes in allogeneic MDDC/CD3+ lymphocyte cultures. This effect has previously been shown for IL-36β and IL-36γ
[1], although our results indicate that IL-36α is less potent than IL-36β in this regard.
These results are also in accordance with a recent murine study which reported that IL-36β induced the expression of maturation markers on the surface of bone marrow derived dendritic cells (BMDDC) and promotes Th1 proliferation in vitro and in vivo [17] . However, our study also shows that IL-36α has a differential effect on the expression of co-stimulatory molecules, having no effect on CD80 or CD86 expression but increasing CD40 expression. This is different to the previously reported effect of IL-36 β which induces both CD40 and CD80 expression on the surface of human MDDCs [1] and probably also reflect the reduced effect of IL-36α compared to IL-36β. It could also be the case that IL-36α and IL-36β differentially effect the production of IL-36RA, which although not tested here is an inhibitor of both cytokines via IL-36R. However, IL-36α did not increase the effect of IFN-γ on the expression of standard maturation markers such as HLA-DR, CD83 or CD1a and generally IL-36α only weakly induced HLA-DR expression, when compared to IFN-γ. However, these results may also show a different effect of the novel IL-1 cytokines when compared to IL-1β since a previous study has shown that both IL-1β and IFN-γ induce maturation of human MDDC and that these 2 cytokines synergise to increase this effect [2] .
The immune response to Gram negative bacteria requires not only the induction of Th1 responses by APCs but also, initially, that the APCS can detect the presence of the bacteria. We therefore investigated the effect of IL-36α on CD14 expression and whether any additional affect on expression was provided by IFN-γ, which is an important cytokine in response to Gram negative bacteria. CD14 is an essential component in the detection of bacterial LPS [18] and CD14 gene knock-out mice are resistant to endotoxaemia induced by LPS injection [19] . Furthermore, LPS binding of CD14 decreases its spatial proximity to Toll-like receptor 4 (TLR4) and it is via TLR4 that the intracellular signalling cascade, which results in the production of proinflammatory cytokines, is initiated [20] . More recently it has been reported that CD14 also augments murine TLR4 endocytosis by dendritic cells, induced by LPS [21] . Our results showed that both IL-36α and IFN-γ upregulated expression of CD14, when compared with unstimulated MDDCs, whereas LPS was unable to do so.
Previous studies have shown that LPS upregulates CD14 expression by human monocytes, which were also stimulated for 48h [22] . However, when MDDCs were cultured with IL-36α and IFN-γ, CD14 expression on the surface of MDDCs increased even further. Thus, IFN-γ synergises with IL-36α to induce high levels of CD14 expression by human MDDCs. Therefore CD14 expression, which is lost when monocytes differentiate into MDDCs, is replenished when MDDCs are cultured with IL-36α and this effect of IL-36α is synergistically enhanced by IFN-γ.
We also investigated whether, or not, these cytokines affected expression of CD11c.
CD11c is a receptor for iC3b, which opsonizes micro-organisms to increase phagocytosis [15] , while transfection of CD11c genes into CHO cells has been shown to induce LPS responsiveness [16] . Thus, expression of both CD11c and CD14 are required for the efficient detection and phagocytosis of Gram negative bacteria such as Salmonella. Furthermore, when CD11c is blocked on the surface of Langerhans cells, proliferation of allogeneic T lymphocytes is prevented [23] , which suggests that CD11c is a vital molecule in the induction of adaptive immunity (atleast allogeneic response) by DCs. As monocytes differentiate into (immature) MDDC, CD11c is expressed on their cell membrane but our results showed that when immature MDDCs were cultured with IL-36α, IL-36β or IFN-γ, expression of CD11c was supressed, while culture of MDDCs with LPS had no effect on CD11c. This latter result is in accordance with a recent study which has reported that LPS down-regulates expression of CD11c by murine splenic DCs and BMDCs but fails to do so in human
MDDCs [24] . However, when we cultured MDDCs with either IL-36α and IFN-γ or IL-36β and IFN-γ, the expression of CD11c was restored to the high levels expressed by immature (unstimulated) MDDCs. In accordance with these results, we also found that IL-36α and IFN-γ synergised to increase binding of iC3b. The role of CD11c in bacterial uptake by human MDDCs is, however, complex since one study has shown that blockade of CD11c has little effect on uptake of opsonized yeast particles and in this study CD11b appeared to be the most dominant complement receptor [25] . In contrast, Ben Nasr et al., (2006) [26] have previously reported that uptake of the Gram negative bacteria Francisella tularensis is dependent on both CD11c and CD11b. In our study we show that although increased CD11c expression due to IL-36α/IFN-γ synergy was also associated with increased iC3b binding to MDDCs this
was not fully correlated with Salmonella uptake. Our results showed that although IL-36 α increased S. Typhimurium uptake by MDDCs and that this was increased to significant levels when MDDCs were cultured with IL-36 α and IFN-γ, neither of these treatments increased uptake above that measured when MDDCs were incubated with IFN-γ alone. We did not study the effect of IL-36α on CD11b expression (as investigated in previous studies mentioned above) and so it is possible that although FACS analyses were used to measure expression of CD14 and CD11c on the surface of MDDCs cultured with IL-1 cytokines (500 ng/ml) and IFN-γ (100 ng/ml) for 48h. 
